Quality · Access · Hope
Countries

🇪🇸 Country Profile

Spain

Expanding pharmaceutical supply to Spain

🇪🇸 $119M
Dual-source profile. Both series show finished pharmaceutical products aligned to calendar year (Jan–Dec). Eurostat records what Spain imports from India. DGCIS records what India exports to Spain. Category and product detail from DGCIS.
$119M
Scale
Spain's healthcare system receives $119M in Indian pharmaceutical products each year — affordable, quality medicine.
45%
Medicine
A diverse pharmaceutical mix: medicine ingredients, medicines, and surgical & hospital supplies each contributing significantly.
2.3×
Trajectory
Spain's imports of Indian pharmaceutical products have grown 2.3× over the past decade — from $51.9M in 2014 to $119M in 2025.
Context
Part of India's pharmaceutical supply network across Europe.
✦
Impact
Indian pharmaceutical companies have both exported to and invested directly in Spain — building trade and operational presence.
Export Trend Eurostat CY DGCIS India-reported
Beyond Finished Medicines DGCIS CY 2014–2025

Additional pharmaceutical categories from DGCIS — APIs, surgical, herbal, and more

Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $119M (44.6%) Medicines $106M (39.7%) Surgical & Hospital Supplies $31.1M (11.7%) Traditional & Herbal $10.8M (4.0%)
Top Products — FY 2025–26 DGCIS
Active Pharmaceutical Ingredients DGCIS India-side

India also supplied $123M in active pharmaceutical ingredients and bulk drugs to Spain in 2025 (India-reported, DGCIS).

Indian Pharma Investment in Spain Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Spain: $12.9M across 15 filings (2013-2021).